Search filters

List of works by Vincenzo Spagnuolo

A nucleoside-sparing regimen of dolutegravir plus ritonavir-boosted atazanavir in HIV-1-infected patients with virological failure: the DOLATAV study

article

An evaluation of cabotegravir for HIV treatment and prevention

scientific article published on 28 October 2020

An observational, retrospective analysis evaluating switching to raltegravir plus abacavir/lamivudine in HIV-1-infected patients: the ORASWIRAL study.

scientific article published on 11 September 2017

Analytical treatment interruption in chronic HIV-1 infection: time and magnitude of viral rebound in adults with 10 years of undetectable viral load and low HIV-DNA (APACHE study)

scientific article published on 01 July 2019

Associations of statins and antiretroviral drugs with the onset of type 2 diabetes among HIV-1-infected patients

scientific article

Atazanavir/ritonavir monotherapy: 96 week efficacy, safety and bone mineral density from the MODAt randomized trial

scientific article published on 5 March 2016

Bictegravir

scientific article published on 01 July 2018

Brief Report: Hyperbilirubinemia Is Associated With a Decreased Risk of Carotid Atherosclerosis in HIV-Infected Patients on Virological Suppression

article

Cardiovascular risk and dyslipidemia among persons living with HIV: a review

scientific article published on 9 August 2017

Cerebrospinal fluid analysis for HIV replication and biomarkers of immune activation and neurodegeneration in long-term atazanavir/ritonavir monotherapy treated patients

scientific article published on July 2016

Changes in darunavir/r resistance score after previous failure to tipranavir/r in HIV-1-infected multidrug-resistant patients

scientific article published in February 2009

Chronic Hepatitis B and C Virus Infection and Risk for Non-Hodgkin Lymphoma in HIV-Infected Patients: A Cohort Study

scientific article

Clinical outcomes of two-drug regimens vs. three-drug regimens in antiretroviral treatment-experienced people living with HIV

scientific article published on 23 December 2020

Clinical, virologic, and immunologic outcomes in lymphoma survivors and in cancer-free, HIV-1-infected patients: a matched cohort study

scientific article published on 26 April 2013

Cross-resistance Profile of the Novel Integrase Inhibitor Dolutegravir (S/GSK1349572) Using Clonal Viral Variants Selected in Patients Failing Raltegravir

scientific article published in 2011

Darunavir for the treatment of HIV infection

article

Durability of switch regimens based on rilpivirine or on integrase inhibitors, both in association with tenofovir and emtricitabine, in HIV-infected, virologically suppressed patients

scientific article published on 16 November 2017

Dynamic patterns of human immunodeficiency virus type 1 integrase gene evolution in patients failing raltegravir-based salvage therapies

scientific article

Efficacy and safety in clinical practice of a rilpivirine, tenofovir and emtricitabine single-tablet regimen in virologically suppressed HIV-positive patients on stable antiretroviral therapy

scientific article published on 30 July 2015

Efficacy and safety of switching from branded to generic antiretrovirals in virologically suppressed HIV-infected patients

scientific article published on August 2017

Efficacy of elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate as treatment for primary or recent HIV infection-authors' response

scientific article published on 14 March 2017

Efficacy of elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate as treatment for primary or recent HIV infection.

scientific article

Evolution of HIV-1 transmitted drug resistance in Italy in the 2007–2014 period: A weighted analysis

article

Evolution patterns of raltegravir-resistant mutations after integrase inhibitor interruption

scientific article

Genotypic/phenotypic patterns of HIV-1 integrase resistance to raltegravir.

scientific article published on 7 January 2010

Glucose tolerance in HIV-1 treated patients who switched from boosted-protease inhibitors to etravirine

scientific article published in October 2013

HIV DNA loads, plasma residual viraemia and risk of virological rebound in heavily treated, virologically suppressed HIV-infected patients.

scientific article published on 13 October 2014

Immortal time bias: authors' reply

scientific article published in April 2015

Immune recovery and T cell subset analysis during effective treatment with maraviroc

scientific article published on 7 June 2012

Immune response to hepatitis B vaccination in HIV-positive individuals with isolated antibodies against hepatitis B core antigen: Results of a prospective Italian study.

scientific article published on September 2017

Incidence and Predictors of Serological Treatment Response in Early and Late Syphilis Among People Living With HIV

article

Increased dose of dolutegravir as a potential rescue therapy in multi-experienced patients

scientific article published on 01 January 2019

Integrase and fusion inhibitors transmitted drug resistance in naive patients with recent diagnosis of HIV-1 infection

scientific article published in February 2011

Is statin preventing cancer in HIV-1 infected individuals? An inappropriate methodology is a more likely explanation: authors' reply

scientific article published in April 2015

Levels of soluble endothelial protein C receptor are associated with CD4+ changes in Maraviroc-treated HIV-infected patients

scientific article (publication date: 2012)

Long-term glucose tolerance in highly experienced HIV-infected patients receiving nucleoside analogue-sparing regimens

scientific article published in September 2012

Monotherapy With Atazanavir as a Simplificati Strategy

Mortality of HIV-infected patients with or without cancer: comparison with the general population in Italy

scientific article published on 18 November 2011

Optimal dietary calcium intake in HIV treated patients: no femoral osteoporosis but higher cardiovascular risk

scientific article published on 12 July 2013

Pharmacotherapeutic management of HIV in transplant patients

scientific article published on 13 May 2019

Plasma fibroblast growth factor 23 and osteocalcin serum levels are associated with cardiovascular risk in HIV-1-infected patients receiving antiretroviral treatment

scientific article published on 27 June 2013

Prior Therapy Influences the Efficacy of Lamivudine Monotherapy in Patients With Lamivudine-Resistant HIV-1 Infection

article

Refining criteria for selecting candidates for a safe lopinavir/ritonavir or darunavir/ritonavir monotherapy in HIV-infected virologically suppressed patients

scientific article

Residual viraemia does not influence 1 year virological rebound in HIV-infected patients with HIV RNA persistently below 50 copies/mL

article

Residual viraemia does not influence 1 year virological rebound in HIV-infected patients with HIV RNA persistently below 50 copies/mL--authors' response

article

Simplification to atazanavir/ritonavir monotherapy for HIV-1 treated individuals on virological suppression: 48-week efficacy and safety results

scientific article

Statins and aspirin in the prevention of cardiovascular disease among HIV-positive patients between controversies and unmet needs: review of the literature and suggestions for a friendly use

article

Ten-year survival among HIV-1-infected subjects with AIDS or non-AIDS-defining malignancies

article

Time spent with residual viraemia after virological suppression below 50 HIV-RNA copies/mL according to type of first-line antiretroviral regimen

article

Uptake and Discontinuation of Integrase Inhibitors (INSTIs) in a Large Cohort Setting

scientific article published on 01 March 2020

Use of statins and risk of AIDS-defining and non-AIDS-defining malignancies among HIV-1 infected patients on antiretroviral therapy

scientific article

Virologic and immunologic outcomes of treatment with integrase inhibitors in a real-world setting: The RESPOND cohort consortium

scientific article published on 31 December 2020

Virological rebound in human immunodeficiency virus-infected patients with or without residual viraemia: results from an extended follow-up.

scientific article published on 24 July 2013

Paulina is supported by:

About Paulina

Help